Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
Gil-Gil, Miguel J., Bellet, M., Morales, S., Ojeda, B., Manso, L., Mesia, C., Garcia-Martínez, E., Martinez-Jáñez, N., Melé, M., Llombart, A., Pernas, S., Villagrasa, P., Blasco, C., Baselga, J.
Published in Breast cancer research and treatment (01.06.2015)
Published in Breast cancer research and treatment (01.06.2015)
Get full text
Journal Article
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno
Published in Breast cancer research and treatment (01.07.2024)
Published in Breast cancer research and treatment (01.07.2024)
Get full text
Journal Article
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
Cortes, J., Perez-Garcia, J., Levy, C., Gómez Pardo, P., Bourgeois, H., Spazzapan, S., Martínez-Jañez, N., Chao, T.-C., Espié, M., Nabholtz, J.M., Gonzàlez Farré, X., Beliakouski, V., Román García, J., Holgado, E., Campone, M.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience
Pérez Ramírez, S., del Monte-Millán, M., López-Tarruella, S., Martínez Jáñez, N., Márquez-Rodas, I., Lobo Samper, F., Izarzugaza Perón, Y., Rubio Terres, C., Rubio Rodríguez, D., García-Sáenz, J. Á., Moreno Antón, F., Zamora Auñón, P., Arroyo Yustos, M., Lara Álvarez, M. Á., Ciruelos Gil, E. M., Manso Sánchez, L., Echarri González, M. J., Guerra Martínez, J. A., Jara Sánchez, C., Bueno Muiño, C., García Adrián, S., Carrión Galindo, J. R., Valentín Maganto, V., Martín, M.
Published in Clinical & translational oncology (01.05.2020)
Published in Clinical & translational oncology (01.05.2020)
Get full text
Journal Article
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Ciruelos, E., Vidal, M., Martínez de Dueñas, E., Martínez-Jáñez, N., Fernández, Y., García-Sáenz, J. A., Murillo, L., Carabantes, F., Beliera, A., Fonseca, R., Gavilá, J.
Published in Clinical & translational oncology (01.06.2018)
Published in Clinical & translational oncology (01.06.2018)
Get full text
Journal Article
Use of bevacizumab as a first-line treatment for metastatic breast cancer
Manso, L, Moreno, F, Márquez, R, Castelo, B, Arcediano, A, Arroyo, M, Ballesteros, A I, Calvo, I, Echarri, M J, Enrech, S, Gómez, A, González Del Val, R, López-Miranda, E, Martín-Angulo, M, Martínez-Jañez, N, Olier, C, Zamora, P
Published in Current oncology (Toronto) (01.04.2015)
Published in Current oncology (Toronto) (01.04.2015)
Get full text
Journal Article
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
Mouron, S, Bueno, M J, Lluch, A, Manso, L, Calvo, I, Cortes, J, Garcia-Saenz, J A, Gil-Gil, M, Martinez-Janez, N, Apala, J V, Caleiras, E, Ximénez-Embún, Pilar, Muñoz, J, Gonzalez-Cortijo, L, Murillo, R, Sánchez-Bayona, R, Cejalvo, J M, Gómez-López, G, Fustero-Torre, C, Sabroso-Lasa, S, Malats, N, Martinez, M, Moreno, A, Megias, D, Malumbres, M, Colomer, R, Quintela-Fandino, M
Published in Nature communications (07.12.2022)
Published in Nature communications (07.12.2022)
Get full text
Journal Article
P006 Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
González-Santiago, S., Gil-Gil, M., Carrasco, E., Martínez-Jáñez, N., Adamo, B., Antolín, S., Alonso, J.L., Vethencourt, A., Martínez-Vila, C., Galve, E., Rojo, F., Caballero, R., Casas, M., Cortazar, E., McCulloch, L., Vedovato, J.-C., Martín, M.
Published in Breast (Edinburgh) (01.04.2023)
Published in Breast (Edinburgh) (01.04.2023)
Get full text
Journal Article
1802 Overall survival (OS) from the phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) signaling inhibitor, in AR+ advanced triple-negative breast cancer (aTNBC)
Cortes, J, Crown, J, Awada, A, Schmid, P, Gianni, L, Garcia-Estevez, L, Martinez-Janez, N, Chan, S, Steinberg, J.L, Blaney, M, Tudor, I.C, Uppal, H, Peterson, A, Miller, K, Yardley, D.A, Hudis, C.A, Traina, T.A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
AB0998 Osteoporosis prevalence in post-menopausal patients treated with aromatase inhibitors using bone mineral density values from a spanish population
Loarce-Martos, J., Sifuentes-Giraldo, W.A., Maldonado-Romero, L.V., Ahijón-Lana, M., Velázquez-Arce, C., Martínez-Jañez, N., Vázquez-Díaz, M.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
121P Impact of HER2 low (H2L) expression on prognosis in luminal locally advanced or metastatic breast cancer (BC): A retrospective study
Saavedra Serrano, C., Pérez Mies, B., Gion Cortes, M., Cortes Salgado, A., Fernández Abad, M., Martinez-Jañez, N., Soriano, M., Guerra, E.M., Miranda, E. Lopez
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
AB0901 Bone Mineral Density and Morphometric Vertebral Deformities in Postmenopausal Women Receiving Aromatase Inhibitors for Breast Cancer
Maldonado-Romero, L.V., Ahijόn-Lana, M., Velázquez-Arce, C., Sifuentes Giraldo, W.A., Martínez Jañez, N., Vázquez Díaz, M.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer
Cazzaniga, M.E., Martinez Jañez, N., Kukielka-Budny, B.D., Ulanska, M., Bourgeois, H., Muñoz Mateu, M., Morales Murillo, S., Bayo, J., Cortesi, L., Pinter, T., Palacova, M., Cherciu, N., Petru, E., Ettl, J., De Almeida, C., Raymond, R., Villanova, G.R., Thanh Minh, C. Ta, Rodrigues, A.C.F., Freyer, G.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
130TiP SOLTI-1303 PATRICIA 2 randomized phase II trial of palbociclib plus trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer (BC) with PAM50 luminal intrinsic subtype
Ciruelos, E.M., Garcia, A.A., Cortés, J., Pernas Simon, S., Garate, E., Melé, M., Montaño, Á., Martinez-Jañez, N., Oliveira, M., Haba-Rodríguez, J. de la, Vega, E., Martorell, A. Perello, Bermejo De Las Heras, B., Cantos Sanchez De Ibarguen, B., Martínez, E., Navarro, E. Vila, Pascual, T., González-Farré, X., Villagrasa, P., Prat, A.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
94MO Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2- endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
Tibau, A., Martinez, M.T., Ramos, M., De la Cruz-Merino, L., Santaballa, A., Connor, M. O', Martinez-Jañez, N., Moreno, F., Fernandez-Perez, I., Virizuela, J.A., Alarcón, J., de la Haba-Rodríguez, J., Sánchez-Rovira, P., Albacar, C.R., Bueno, C., Kelly, C., Casas, M., Bezares, S., Rosell, L., Albanell, J.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)
Albanell, J., Martinez, M.T.M., Ramos, M., Connor, M.O.', De la Cruz-Merino, L., Santaballa Bertran, A., Martínez-Jáñez, N., Moreno, F., Fernández Pérez, I., Alarcon Company, J., Virizuela Echaburu, J.A., De la Haba Rodríguez, J., Sánchez-Rovira, P., González-Cortijo, L., Margeli Vila, M., Sánchez Munoz, A., Garau Llinas, I., Casas, M., Bezares Montes, S., Rojo Todo, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Abstract P1-10-07: Efficacy and safety results from a randomized, phase II study of CC-486 in combination with fulvestrant in postmenopausal women with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2−) metastatic breast cancer (MBC)
Campone, M, Sachdev, J, Bianchi, GV, Beck, JT, Martínez-Jáñez, N, Cortes, J, Schmidt, M, Zamagni, C, Chen, P, Miller, J, Fandi, A, Gianni, L
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
5PSQ-085 Real-world safety and tolerability of palbociclib as first-line therapy in patients with locally advanced or metastatic breast cancer
Martinez Barros, H, Sanchez-Cuervo, M, Martinez-Jañez, N, Alvarez-Diaz, AM
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Get full text
Journal Article
154TiP TACTIVE-N: Open-label, randomized, noncomparative neoadjuvant phase 2 study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, or anastrozole in postmenopausal women with ER+/human epidermal growth factor receptor 2 (HER2)- localized breast cancer
Fasching, P.A., Clifton, K., Katashvili, Z., Nemsadze, G., Makharadze, T., Arkania, E., Gogishvili, M., Lachowicz, M., Gedrich, R., Ranciato, J., Zhi, E., Perkins, J., Jañez, N. Martinez, Hurvitz, S.A.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article